Published in Int J Colorectal Dis on June 26, 2014
Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg (2004) 55.13
Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol (2012) 5.06
Peritonectomy procedures. Ann Surg (1995) 4.24
Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol (1999) 3.21
Pseudomyxoma peritonei. Long-term patient survival with an aggressive regional approach. Ann Surg (1994) 2.50
Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy. Ann Surg (2005) 2.19
Appendiceal neoplasms and pseudomyxoma peritonei: a population based study. Eur J Surg Oncol (2007) 2.17
Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol (1999) 2.02
Survival of patients with pseudomyxoma peritonei treated by serial debulking. Colorectal Dis (2009) 1.49
Consensus statement on the loco-regional treatment of appendiceal mucinous neoplasms with peritoneal dissemination (pseudomyxoma peritonei). J Surg Oncol (2008) 1.41
Pseudomyxoma peritonei. Curr Probl Surg (2008) 1.34
Outcome differences between debulking surgery and cytoreductive surgery in patients with Pseudomyxoma peritonei. Eur J Surg Oncol (2012) 0.83
Carcinomatosis from gastrointestinal cancer. Ann Med (2004) 0.82
Feasibility of radical cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei of appendiceal origin. Scand J Surg (2013) 0.80
The common colorectal cancer predisposition SNP rs6983267 at chromosome 8q24 confers potential to enhanced Wnt signaling. Nat Genet (2009) 5.65
Low-level microsatellite instability in most colorectal carcinomas. Cancer Res (2002) 2.87
Early-onset renal cell carcinoma as a novel extraparaganglial component of SDHB-associated heritable paraganglioma. Am J Hum Genet (2003) 2.43
Explaining the familial colorectal cancer risk associated with mismatch repair (MMR)-deficient and MMR-stable tumors. Clin Cancer Res (2007) 2.24
Prognostic significance of elevated cyclooxygenase 2 expression in patients with adenocarcinoma of the esophagus. Gastroenterology (2002) 2.19
SMAD4 levels and response to 5-fluorouracil in colorectal cancer. Clin Cancer Res (2005) 2.05
Cytoplasmic HuR expression is a prognostic factor in invasive ductal breast carcinoma. Cancer Res (2005) 1.94
MYC-dependent regulation and prognostic role of CIP2A in gastric cancer. J Natl Cancer Inst (2009) 1.80
High frequency of BRAF V600E mutations in ameloblastoma. J Pathol (2014) 1.79
Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients. Cancer Res (2010) 1.69
Coverage and performance of colorectal cancer screening with the faecal occult blood test in Finland. J Med Screen (2011) 1.63
Allelic imbalance at rs6983267 suggests selection of the risk allele in somatic colorectal tumor evolution. Cancer Res (2008) 1.59
Segregation of a missense variant in enteric smooth muscle actin γ-2 with autosomal dominant familial visceral myopathy. Gastroenterology (2012) 1.57
Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. Gastroenterology (2005) 1.56
Few FH mutations in sporadic counterparts of tumor types observed in hereditary leiomyomatosis and renal cell cancer families. Cancer Res (2002) 1.54
Cytoplasmic HuR expression correlates with poor outcome and with cyclooxygenase 2 expression in serous ovarian carcinoma. Cancer Res (2003) 1.50
SMAD4 as a prognostic marker in colorectal cancer. Clin Cancer Res (2005) 1.50
LKB1 signaling in mesenchymal cells required for suppression of gastrointestinal polyposis. Nat Genet (2008) 1.46
Breast cancer patients with p53 Pro72 homozygous genotype have a poorer survival. Clin Cancer Res (2005) 1.46
Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study. Breast Cancer Res (2011) 1.42
Prognostic role of HuR in hereditary breast cancer. Clin Cancer Res (2007) 1.41
CIP2A expression is increased in prostate cancer. J Exp Clin Cancer Res (2010) 1.39
Impact of Screening on Survival in Familial Adenomatous Polyposis. J Clin Gastroenterol (2016) 1.39
Intussusception and spontaneous amputation of the esophagus. J Thorac Cardiovasc Surg (2002) 1.38
Biallelic inactivation of fumarate hydratase (FH) occurs in nonsyndromic uterine leiomyomas but is rare in other tumors. Am J Pathol (2004) 1.37
Cyclooxygenase-2 expression during carcinogenesis in the human stomach. J Pathol (2002) 1.35
Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR. Clin Cancer Res (2005) 1.34
Early-onset gastric cancers have a different molecular expression profile than conventional gastric cancers. Mod Pathol (2006) 1.27
15-hydroxyprostaglandin dehydrogenase is down-regulated in gastric cancer. Clin Cancer Res (2009) 1.23
Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer. J Natl Cancer Inst (2008) 1.22
Unregulated smooth-muscle myosin in human intestinal neoplasia. Proc Natl Acad Sci U S A (2008) 1.20
Diverse roles for chloroplast stromal and thylakoid-bound ascorbate peroxidases in plant stress responses. Biochem J (2008) 1.17
Outcome of patients after endoluminal stent placement for benign colorectal obstruction. Scand J Gastroenterol (2010) 1.16
Ski-related novel protein N (SnoN), a negative controller of transforming growth factor-beta signaling, is a prognostic marker in estrogen receptor-positive breast carcinomas. Cancer Res (2003) 1.14
Gastric cancer: basic aspects. Helicobacter (2012) 1.11
Family history, surgery, and APC mutation are risk factors for desmoid tumors in familial adenomatous polyposis: an international cohort study. Dis Colon Rectum (2011) 1.11
Elevated cyclooxygenase-2 expression is associated with altered expression of p53 and SMAD4, amplification of HER-2/neu, and poor outcome in serous ovarian carcinoma. Clin Cancer Res (2004) 1.11
BMPR1A mutations in hereditary nonpolyposis colorectal cancer without mismatch repair deficiency. Gastroenterology (2011) 1.10
Candidate driver genes in microsatellite-unstable colorectal cancer. Int J Cancer (2011) 1.08
Gastric cancer: basic aspects. Helicobacter (2011) 1.08
Antiangiogenic arming of an oncolytic vaccinia virus enhances antitumor efficacy in renal cell cancer models. J Virol (2009) 1.06
Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer. Breast Cancer Res Treat (2005) 1.06
Expression of microsomal prostaglandin E synthase-1 in intestinal type gastric adenocarcinoma and in gastric cancer cell lines. Int J Cancer (2003) 1.05
Tissue-specific promoters active in CD44+CD24-/low breast cancer cells. Cancer Res (2008) 1.05
Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer. Int J Cancer (2014) 1.02
Toward a Molecular Classification of Colorectal Cancer: The Role of BRAF. Front Oncol (2013) 1.02
Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3beta in gastric cancer cells. J Biol Chem (2005) 1.02
Preferential amplification of AURKA 91A (Ile31) in familial colorectal cancers. Int J Cancer (2006) 1.02
CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer. Tumour Biol (2005) 1.01
Genetic and epigenetic alteration in gastric carcinogenesis. Helicobacter (2010) 1.01
Low-penetrance susceptibility variants in familial colorectal cancer. Cancer Epidemiol Biomarkers Prev (2010) 1.01
p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome. Clin Cancer Res (2005) 1.01
COX-2 is associated with proliferation and apoptosis markers and serves as an independent prognostic factor in gastric cancer. Tumour Biol (2009) 1.00
Eleven candidate susceptibility genes for common familial colorectal cancer. PLoS Genet (2013) 0.98
Stenting for malignant colorectal obstruction: a single-center experience with 101 patients. Surg Endosc (2011) 0.98
CIP2A overexpression is associated with c-Myc expression in colorectal cancer. Cancer Biol Ther (2012) 0.97
Suppression of Peutz-Jeghers polyposis by inhibition of cyclooxygenase-2. Gastroenterology (2004) 0.96
BRAF mutation in sporadic colorectal cancer and Lynch syndrome. Virchows Arch (2013) 0.96
Systemic adenoviral gene delivery to orthotopic murine breast tumors with ablation of coagulation factors, thrombocytes and Kupffer cells. J Gene Med (2009) 0.96
Soft-tissue sarcomas of the upper extremity: surgical treatment and outcome. Plast Reconstr Surg (2004) 0.95
Gastric outlet obstruction in gastric cancer: a comparison of three palliative methods. J Surg Oncol (2013) 0.95
EXO1 variants occur commonly in normal population: evidence against a role in hereditary nonpolyposis colorectal cancer. Cancer Res (2003) 0.94
Outcome for self-expandable metal stents in malignant gastroduodenal obstruction: single-center experience with 104 patients. Surg Endosc (2010) 0.94
Mutations in the circadian gene CLOCK in colorectal cancer. Mol Cancer Res (2010) 0.93
Little evidence for involvement of MLH3 in colorectal cancer predisposition. Int J Cancer (2003) 0.93
Causes of death of mutation carriers in Finnish Lynch syndrome families. Fam Cancer (2012) 0.92
VEGF-C and COX-2 expression in papillary thyroid cancer. Endocr Relat Cancer (2006) 0.92
Identification of candidate oncogenes in human colorectal cancers with microsatellite instability. Gastroenterology (2013) 0.92
COX-2 inhibitors and genetic background reduce mammary tumorigenesis in cyclooxygenase-2 transgenic mice. Prostaglandins Other Lipid Mediat (2005) 0.92
Targeted therapy in gastric cancer. APMIS (2015) 0.91
Serrated polyps of the colon: how reproducible is their classification? Virchows Arch (2012) 0.91
Systematic search for enhancer elements and somatic allelic imbalance at seven low-penetrance colorectal cancer predisposition loci. BMC Med Genet (2011) 0.91
Increased expression of cytoplasmic HuR in familial adenomatous polyposis. Cancer Biol Ther (2007) 0.91
Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice. Cancer Res (2003) 0.91
Cyclooxygenase-2 and gastric cancer. Cancer Metastasis Rev (2011) 0.90
Prognostic significance of cyclin A in gastric cancer. Int J Cancer (2006) 0.90
Prognostic factors in papillary thyroid cancer: an evaluation of 601 consecutive patients. Tumour Biol (2005) 0.90
Somatic mutations and germline sequence variants in patients with familial colorectal cancer. Int J Cancer (2010) 0.89
Mutations in Exon 1 highlight the role of MED12 in uterine leiomyomas. Hum Mutat (2014) 0.89
HuR expression is a marker of poor prognosis in renal cell carcinoma. Tumour Biol (2010) 0.89
Chlorpromazine and apigenin reduce adenovirus replication and decrease replication associated toxicity. J Gene Med (2007) 0.88
Exome sequencing in diagnostic evaluation of colorectal cancer predisposition in young patients. Scand J Gastroenterol (2013) 0.88
Cytoplasmic HuR expression correlates with epithelial cancer cell but not with stromal cell cyclooxygenase-2 expression in mucinous ovarian carcinoma. Gynecol Oncol (2005) 0.87
CD2AP contributes to cell migration and adhesion in cultured gastric epithelium. Biochem Biophys Res Commun (2005) 0.87
Basic aspects of gastric cancer. Helicobacter (2009) 0.87
Retracted Cyclooxygenase-2 (COX-2) expression in high-risk premalignant oral lesions. Oral Oncol (2003) 0.87
Genomic profile of pseudomyxoma peritonei analyzed using next-generation sequencing and immunohistochemistry. Int J Cancer (2014) 0.87
Role of RNA binding protein HuR in ductal carcinoma in situ of the breast. J Pathol (2011) 0.85
Mutations in two short noncoding mononucleotide repeats in most microsatellite-unstable colorectal cancers. Cancer Res (2005) 0.85
Implication of chlorophyll biosynthesis on chloroplast-to-nucleus retrograde signaling. Plant Signal Behav (2009) 0.84
Estimating the probability of cancer with several tumor markers in patients with colorectal disease. Oncology (2004) 0.84
Psychosocial consequences of predictive genetic testing for Lynch syndrome and associations to surveillance behaviour in a 7-year follow-up study. Fam Cancer (2013) 0.84
Exome sequencing reveals three novel candidate predisposition genes for diffuse gastric cancer. Fam Cancer (2015) 0.84